Current Issue - November 2015, Volume 9, Issue No. 3

1. Sengupta S. Congenital dislocation of hip in Malaysia. Indian J Surg 1973; 35(7): 322-6.
2. Boo NY, Rajaram T. Congenital dislocation of hips in Malaysia neonates. Sing Med J 1989; 30: 368-71.
3. Rebello G, Joseph B. Late presentation of developmental dysplasia of the hip in children from southwest India – Will screening help? Indian J Orthop 2003; 37: 210-4.
4. Asim AM, A Saw, M Nawar. Treatment of Developmental Dysplasia of the Hip: Short and Mid-term Outcome. Malays Orthop J. 2011; 5(1): 17-20.
5. Tredwell SJ. Neonatal screening for hip joint instability. Its clinical and economic relevance. Clin Orthop Relat Res. 1992 ; (281):63-8.
6. Fees (Medical) (Amendment) Order, (2003); P.U(A) 6/2003: 235-1112.
7. Logistic Pharmacy Store (Non-medication Registry). Department of Pharmacy, Penang Hospital (2015): 1-19.
8. Full Paying Patient (FPP) Guideline 2007 Modified 2015 Ministry of Health of Malaysia.
9. Medical Registry. Integration Store Unit. Department of Pharmacy, Penang Hospital (2014): 2-7.
10. Gul R, Coffey JC, Khayyat G, McGuinness AJ. Late presentation of developmental dysplasia of the hip. 2002; Irish J Med Sc.171(3): 139-40.
11. Clarke NM1, Reading IC, Corbin C, Taylor CC, Bochmann T. Twenty years experience of selective secondary ultrasound screening for congenital dislocation of the hip. Arch Dis Child. 2012; 97(5): 423-9.
12. Cady RB. Developmental dysplasia of the hip: definition, recognition, and prevention of late sequelae. Pediatr Ann. 2006 ; 35(2):92-101.

Abstract   |   Reference